Global Health Limited (MEDANTA) Releases Q2 FY27 Earnings Conference Call Transcript
Global Health Limited (MEDANTA) released its Q2 FY27 earnings call transcript. The company achieved EBITDA breakeven at its Noida hospital and announced a ₹1,000 crore capex for a new 500-bed hospital in Ghaziabad. Q2 FY27 revenue from operations grew 34% YoY to ₹14,690 million, with operating EBITDA up 60% YoY to ₹3,701 million.
The announcement includes substantial financial growth figures, a major land acquisition for a new hospital, and a clear expansion strategy that will significantly impact the company's future capacity and market presence.
The announcement details strong financial performance, successful operational milestones like the Noida hospital achieving EBITDA breakeven, and significant expansion plans, all indicating positive business momentum.
Global Health Limited (MEDANTA) has released the transcript of its Earnings Conference Call held on November 04, 2026, to discuss the results for the Second Quarter and Half-Year ended September 30, 2026. The call featured management including Dr. Naresh Trehan (Chairman and Managing Director), Mr. Pankaj Sahni (Group CEO and Director), and Mr. Yogesh Kumar Gupta (Chief Financial Officer).
Key highlights from the call included the strong performance of the Noida hospital, which achieved EBITDA breakeven within a year of its inauguration. The company also announced the acquisition of a 2.61-acre land parcel in Ghaziabad for a planned 500-bed multi-specialty hospital, with a total capex of approximately ₹1,000 crores. This expansion is part of a larger pipeline of 6 new greenfield hospitals aimed at doubling the company's bed capacity.
Financially, for Q2 FY27, consolidated revenue from operations grew by 34% year-on-year to ₹14,690 million. Operating EBITDA increased by 60% year-on-year to ₹3,701 million, with margins improving to 25.2% from 21% in Q2 FY26. Profit after tax for the quarter was ₹2,191 million, a 38% increase year-on-year. The company reported a net cash surplus of ₹7,815 million as of September 30, 2026.
Operationally, inpatient volumes increased by 30% year-on-year, and outpatient volumes grew by 38%. Network occupancy improved to 67% on expanded bed capacity. Investments in technology and specialized infrastructure were also highlighted, including new equipment at Gurugram and Patna hospitals. The company plans to add approximately 3,450 beds over the next few years, supported by a planned capital expenditure of over ₹6,000 crores.
What to do with a filing like this
Global Health Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Global Health Limited. Read the original for the full detail.